• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer.患者报告结局在非小细胞肺癌根治性放化疗中的应用
Transl Lung Cancer Res. 2020 Feb;9(1):154-155. doi: 10.21037/tlcr.2019.12.12.
2
Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.局部晚期非小细胞肺癌根治性放化疗后局部复发行挽救性手术后的长期生存情况
Thorac Cardiovasc Surg. 2018 Mar;66(2):135-141. doi: 10.1055/s-0037-1606597. Epub 2017 Oct 9.
3
Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?对于局部晚期非小细胞肺癌，在进行根治性放化疗后出现局部复发时，是否应考虑挽救性手术？
J Cardiothorac Surg. 2016 Jan 19;11:9. doi: 10.1186/s13019-016-0396-0.
4
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer.放化疗联合治疗可提高 III 期老年非小细胞肺癌患者的生存率。
J Thorac Oncol. 2018 Mar;13(3):426-435. doi: 10.1016/j.jtho.2017.11.135. Epub 2018 Jan 8.
5
Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.在 IIIA 期 N2 非小细胞肺癌的治疗中，与根治性放化疗相比，新辅助放化疗联合手术可改善生存结局。
Eur J Cardiothorac Surg. 2015 Nov;48(5):684-90; discussion 690. doi: 10.1093/ejcts/ezu504. Epub 2015 Jan 6.
6
Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.非小细胞肺癌根治性放化疗后的挽救性手术
Semin Thorac Cardiovasc Surg. 2017;29(2):233-241. doi: 10.1053/j.semtcvs.2017.02.001. Epub 2017 Feb 24.
7
[Lung Resection after Definitive and Neo-Adjuvant Chemoradiation for Stage IIIA/B Locally Advanced Non-Small Cell Lung Cancer: a Retrospective Analysis].[ⅢA/B期局部晚期非小细胞肺癌根治性及新辅助放化疗后的肺切除术：一项回顾性分析]
Zentralbl Chir. 2018 Jun;143(3):307-315. doi: 10.1055/a-0584-7886. Epub 2018 Jun 22.
8
Definitive treatment patterns and survival in stage II non-small cell lung cancer.局限期 II 期非小细胞肺癌的明确治疗模式和生存情况。
Lung Cancer. 2018 Oct;124:135-142. doi: 10.1016/j.lungcan.2018.07.035. Epub 2018 Jul 24.
9
Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival.根治性放化疗后进行肺切除术与可接受的生存相关。
Eur J Cardiothorac Surg. 2013 Jul;44(1):e66-70. doi: 10.1093/ejcts/ezt184. Epub 2013 Apr 4.
10
Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.ⅢA 期非小细胞肺癌的多学科治疗：放化疗联合或不联合手术的长期结果。
Cancer Control. 2014 Jan;21(1):57-62. doi: 10.1177/107327481402100108.

本文引用的文献

1
Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.立体定向体部放疗与手术治疗早期非小细胞肺癌患者报告结局的比较。
Clin Lung Cancer. 2019 Sep;20(5):370-377.e3. doi: 10.1016/j.cllc.2019.04.001. Epub 2019 Apr 25.
2
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.分析癌症临床试验中患者报告的结局和生活质量终点数据：制定国际标准的起点。
Lancet Oncol. 2016 Nov;17(11):e510-e514. doi: 10.1016/S1470-2045(16)30510-1. Epub 2016 Oct 18.
3
Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review.减少患者报告结局（PRO）数据缺失的发生率及影响的设计、实施和报告策略：一项系统综述
BMJ Open. 2016 Jun 15;6(6):e010938. doi: 10.1136/bmjopen-2015-010938.
4
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.常规癌症治疗期间通过患者报告结局进行症状监测：一项随机对照试验。
J Clin Oncol. 2016 Feb 20;34(6):557-65. doi: 10.1200/JCO.2015.63.0830. Epub 2015 Dec 7.
5
Improving an electronic system for measuring PROs in routine oncology practice.改进电子系统，以在常规肿瘤学实践中测量 PROs。
J Cancer Surviv. 2016 Jun;10(3):573-82. doi: 10.1007/s11764-015-0503-6. Epub 2015 Dec 7.
6
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.非小细胞肺癌患者放射剂量递增研究的生活质量分析：放射治疗肿瘤学组 0617 随机临床试验的二次分析。
JAMA Oncol. 2016 Mar;2(3):359-67. doi: 10.1001/jamaoncol.2015.3969.
7
Racial Disparities in Health-Related Quality of Life After Lung Cancer Surgery: Findings From the Cancer Care Outcomes Research and Surveillance Consortium.肺癌手术后健康相关生活质量的种族差异：癌症护理结果研究和监测联盟的研究结果。
J Thorac Oncol. 2015 Oct;10(10):1404-12. doi: 10.1097/JTO.0000000000000629.
8
Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review.解决代表性不足人群临床试验入组障碍的策略：一项系统综述
Contemp Clin Trials. 2014 Nov;39(2):169-82. doi: 10.1016/j.cct.2014.08.004. Epub 2014 Aug 15.
9
Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.非小细胞肺癌在种族、族裔和社会经济地位方面的生存差异。
Cancer J. 2014 Jul-Aug;20(4):237-45. doi: 10.1097/PPO.0000000000000058.
10
Predictors of enrollment in lung cancer clinical trials.肺癌临床试验入组的预测因素。
Cancer. 2006 Jan 15;106(2):420-5. doi: 10.1002/cncr.21638.

Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer.

作者信息

Vogel Jennifer, Lin Lilie, Rengan Ramesh

机构信息

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, MD, USA.

Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Transl Lung Cancer Res. 2020 Feb;9(1):154-155. doi: 10.21037/tlcr.2019.12.12.

DOI:10.21037/tlcr.2019.12.12
PMID:32207751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7082282/
Abstract
摘要